These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38810920)

  • 1. Patient-reported symptomatic events do not adequately reflect atrial arrhythmia.
    Abedin Z; Herner M; Torre M; Zhang Y; Orton C; Lyons A; Bunch TJ; Steinberg BA
    Heart Rhythm; 2024 May; ():. PubMed ID: 38810920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodes of Atrial Fibrillation and Symptoms: A Temporal Analysis.
    Ghanbari H; Whibley D; Lehmann HI; Li Z; Kratz A; Clauw DJ; Nallamothu BK
    Cardiovasc Digit Health J; 2023 Oct; 4(5):143-148. PubMed ID: 37850044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation.
    Hermans ANL; Gawalko M; Slegers DPJ; Andelfinger N; Pluymaekers NAHA; Verhaert DVM; van der Velden RMJ; Betz K; Evens S; Luermans JGLM; den Uijl DW; Baumert M; Nguyen HL; Isaksen JL; Kanters JK; Rienstra M; Vernooy K; Van Gelder IC; Hendriks JM; Linz D
    Int J Cardiol; 2022 Nov; 367():29-37. PubMed ID: 35963443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.
    Andrade JG; Deyell MW; Verma A; Macle L; Champagne J; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Khairy P; Nattel S
    JAMA Netw Open; 2020 Jul; 3(7):e208748. PubMed ID: 32614422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
    Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
    JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality-of-Life Score: The CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry.
    Kim JY; Park HS; Park HW; Choi EK; Park JK; Kim JB; Kang KW; Shim J; Joung B; Park KM
    J Am Heart Assoc; 2022 Sep; 11(18):e025956. PubMed ID: 36073646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation for atrial fibrillation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
    Disertori M; Lombardi F; Barlera S; Maggioni AP; Favero C; Franzosi MG; Lucci D; Staszewsky L; Fabbri G; Quintarelli S; Bianconi L; Latini R
    Am Heart J; 2011 Aug; 162(2):382-9. PubMed ID: 21835301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
    Connolly SJ; Schnell DJ; Page RL; Wilkinson WE; Marcello SR; Pritchett EL;
    Am Heart J; 2003 Sep; 146(3):489-93. PubMed ID: 12947368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding atrial symptom reports: objective versus subjective predictors.
    Sears SF; Serber ER; Alvarez LG; Schwartzman DS; Hoyt RH; Ujhelyi MR
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):801-7. PubMed ID: 16105008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
    Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study.
    Leclercq F; Odorico X; Marin G; Christophe Macia J; Delseny D; Agullo A; Pages L; Robert P; Lattuca B; Cayla G; Roubille F; Gaillard N; Arquizan C; Akodad M
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100919. PubMed ID: 34849392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Swiryn S; Orlov MV; Benditt DG; DiMarco JP; Lloyd-Jones DM; Karst E; Qu F; Slawsky MT; Turkel M; Waldo AL;
    Circulation; 2016 Oct; 134(16):1130-1140. PubMed ID: 27754946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.